Hemolytic Uremic Syndrome, Genetic
The nomenclature of atypical hemolytic uremic syndrome (aHUS) has undergone an evolution as rapid as the scientific understanding of the field during the last decade. Identification of many underlying genetic causes has increased understanding of the major mechanisms of disease. These defects principally, but not exclusively, involve the alternative pathway of complement. Important differences among the specific defects have impact on disease management, and clinical genetics plays a key role in that process. Untreated, aHUS frequently leads to end stage renal disease or death. Fortunately, understanding the major disease mechanisms has allowed development of effective treatment options.
KeywordsHemolytic uremic syndrome Complement Alternative pathway Hemolytic anemia Thrombocytopenia Thrombotic microangiopathy Factor H Eculizmuab Plasmapheresis Plasma exchange
- Goodship TH, Cook HT, Fakhouri F, Fervenza FC, Fremeaux-Bacchi V, Kavanagh D et al (2017) Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney disease: improving global outcomes” (KDIGO) controversies conference. Kidney Int 91:539–551. 2016 Dec 15CrossRefGoogle Scholar
- Greenbaum L (2016) The physician’s guide to atypical hemolytic uremic syndrome (aHUS). In: (NORD) NOfRD, editor. http://www.nordphysicianguidesorg/wp-content/uploads/2015/12/NORD_Physician%E2%80%99s-Guide-to-AHUS.pdf
- Gurjar BS, Sriharsha TM, Bhasym A, Prabhu S, Puraswani M, Khandelwal P, et al (2018) Characterization of genetic predisposition and autoantibody profile in atypical hemolytic uremic syndrome. Immunology. https://doi.org/10.1111/imm.12916. [Epub ahead of print]. PMID:29485195
- Murphy K (2008) Janeway’s immunobiology, 7th edn. Garland Science, New YorkGoogle Scholar
- Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424CrossRefGoogle Scholar